We are live on ! Find out more
ALXN

Alexion Pharmaceuticals
ALXN

Delisted

ALXN was delisted on the 20th of July, 2021.

Back to rankings

406 hedge funds and large institutions have $17.3B invested in Alexion Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 406 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more call options, than puts

Call options by funds: $149M | Put options by funds: $97.1M

Holders
406
Holders Change
+406
Holders Change %
–
% of All Funds
13.25%
Holding in Top 10
6
Holding in Top 10 Change
+6
Holding in Top 10 Change %
% of All Funds
0.2%
New
406
Increased
–
Reduced
–
Closed
–
Calls
$149M
Puts
$97.1M
Net Calls
+$51.9M
Net Calls Change
+$51.9M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BIM
51
BlackRock Investment Management
Delaware
$45M +$47M +487,837 New
VOYA Investment Management
52
VOYA Investment Management
Georgia
$40.9M +$42.7M +442,919 New
AllianceBernstein
53
AllianceBernstein
Tennessee
$40.2M +$42M +436,051 New
KeyBank National Association
54
KeyBank National Association
Ohio
$39.5M +$40.8M +423,690 New
BlackRock
55
BlackRock
New York
$39.3M +$41.1M +426,458 New
New York State Teachers Retirement System (NYSTRS)
56
New York State Teachers Retirement System (NYSTRS)
New York
$39.3M +$41M +425,663 New
Manulife (Manufacturers Life Insurance)
57
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$38.2M +$39.9M +413,798 New
SB
58
Suntrust Banks
Georgia
$37.6M +$39.3M +408,046 New
Mitsubishi UFJ Trust & Banking
59
Mitsubishi UFJ Trust & Banking
Japan
$37.6M +$39.2M +407,198 New
Allianz Asset Management
60
Allianz Asset Management
Germany
$37.2M +$38.9M +403,201 New
TD Asset Management
61
TD Asset Management
Ontario, Canada
$35.2M +$36.8M +381,630 New
GC
62
Guggenheim Capital
Illinois
$34.9M +$36.4M +377,864 New
TCM
63
Tekla Capital Management
Massachusetts
$34.3M +$35.8M +371,329 New
Charles Schwab
64
Charles Schwab
California
$33.9M +$34.1M +354,094 New
CCI
65
Columbus Circle Investors
$33.4M +$34.8M +361,590 New
NFA
66
Nationwide Fund Advisors
Ohio
$32.6M +$34.1M +353,747 New
Arrowstreet Capital
67
Arrowstreet Capital
Massachusetts
$32.5M +$33.9M +351,868 New
State Board of Administration of Florida Retirement System
68
State Board of Administration of Florida Retirement System
Florida
$32.2M +$33.7M +349,313 New
RhumbLine Advisers
69
RhumbLine Advisers
Massachusetts
$32.1M +$33.5M +348,000 New
California State Teachers Retirement System (CalSTRS)
70
California State Teachers Retirement System (CalSTRS)
California
$31.4M +$32.8M +340,059 New
STC
71
SEI Trust Company
Pennsylvania
$28.7M +$30M +311,334 New
Morgan Stanley
72
Morgan Stanley
New York
$27.6M +$28.8M +299,008 New
Korea Investment Corp
73
Korea Investment Corp
South Korea
$27.4M +$28.6M +297,100 New
First Trust Advisors
74
First Trust Advisors
Illinois
$27M +$28.2M +292,687 New
Two Sigma Investments
75
Two Sigma Investments
New York
$26.8M +$28M +290,598 New
1 2
3
4 5

ALXN Hedge Fund Activity: Q2 2013 in Review

406 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Alexion Pharmaceuticals (ALXN) for Q2 2013, worth a combined $17.3B.

Buyers outnumbered sellers: 406 funds opened new ALXN positions and 0 closed out — a net gain of 406 holders — while 0 added to existing stakes and 0 trimmed.

  • 406 institutional investors held Alexion Pharmaceuticals (ALXN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $17.3B of Alexion Pharmaceuticals stock for Q2 2013.
  • 406 funds opened new Alexion Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +406 holders.

Based on aggregated 13F filings for Q2 2013.